Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Labs v. Sullivan

Executive Summary

Supreme Court lets stand on Oct. 14 the April 16 D.C. federal appellate court decision denying Barr's petition to force FDA to complete ANDA reviews within 180 days. The latest decision was made without comment. The April decision stated that, although FDA's failure to review ANDAs in 180 days does violate a statutory limit, the court lacks the power to force FDA to process ANDAs within the deadline ("The Pink Sheet" April 22, p. 10)....
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019825

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel